PMID: 11920525Mar 29, 2002Paper

A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone

Cancer
Wallace AkerleyLouis Leone

Abstract

Estramustine phosphate (EMP) and vinblastine have radiosensitizing properties and significant activity against hormone refractory prostate carcinoma. Strontium-89 is a palliative agent that acts as a selective radiation source for bone metastasis. The combination of EMP, vinblastine, and strontium-89 was developed to exploit the potential for radiosynergy. PATIENTS AND METHODS Forty-four patients at the Brown Oncology Group affiliated hospitals were treated with oral EMP 600 mg/m2 daily on Weeks 1-4 and 7-10, vinblastine 4 mg/m2 intravenously once each week on Weeks 1-4 and 7-10, and strontium-89 2.2 MBq/kg on Day 1. Courses were repeated every 12 weeks. Response assessment was based on a change in the serum prostate specific antigen (PSA) levels, correlated with change in measurable disease and bone scan appearance. A greater than or equal to 50% decline in PSA for at least 6 weeks was observed in 21 patients (48%, 95% confidence interval, 33-62%). Median duration of response was 23 weeks (range, 6-70.8 weeks). The median survival was 13 months with 1- and 2-year survival rates of 55% and 25%, respectively. After completion of protocol therapy, a retrospective review showed that only nine patients received subsequent palliativ...Continue Reading

References

Nov 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G R HudesR Comis
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V J LewingtonM A Zivanovic
Sep 1, 1991·The British Journal of Radiology·A H LaingM A Zivanovic
Jan 24, 1991·The New England Journal of Medicine·R F Gittes
Jan 1, 1990·Cancer Investigation·R Benson, B Hartley-Asp
Jun 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A EisenbergerM A Friedman
Jan 1, 1986·European Journal of Nuclear Medicine·G M BlakeD M Ackery
Jan 1, 1987·Urological Research·K D Tew, M E Stearns
Jan 5, 1986·Journal of Molecular Biology·M A JordanL Wilson
Nov 15, 1984·The New England Journal of Medicine·UNKNOWN Leuprolide Study Group
Jun 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J H KimM Gabel
Feb 5, 1998·CA: a Cancer Journal for Clinicians·S H LandisP A Wingo
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G HudesB Roth

❮ Previous
Next ❯

Citations

Sep 18, 2007·Medical Oncology·Victor ValdespinoPavel Pisa
Dec 14, 2011·Annals of Nuclear Medicine·Isao Kuroda
Apr 2, 2003·Urology·Douglas ScherrUNKNOWN National Comprehensive Cancer Network
Jun 11, 1999·The Urologic Clinics of North America·J Friedland
May 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D E HeronM Kurman
Jan 23, 2013·The Cancer Journal·Darren BradyJoe M O'Sullivan
Jan 7, 2014·Cancer Metastasis Reviews·Daniel F Camacho, Kenneth J Pienta
Sep 17, 2014·Cancer Biotherapy & Radiopharmaceuticals·Chandan KumarGrace Samuel
Aug 2, 2011·Methods : a Companion to Methods in Enzymology·K Liepe, J Kotzerke
Feb 2, 2010·Seminars in Nuclear Medicine·Fabio M Paes, Aldo N Serafini
Nov 1, 2011·BJU International·Daniel J LeeShahrokh F Shariat
Jun 5, 2003·Expert Opinion on Pharmacotherapy·Eli Rosenbaum, Michael A Carducci
Nov 22, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Glenn BaumanJinka Sathya
Apr 17, 2003·The Oncologist·Michael J Morris, Howard I Scher
Aug 5, 2020·Clinical Oncology : a Journal of the Royal College of Radiologists·A ChallapalliA Bahl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.